The use of tricalcium phosphate to preserve alveolar bone in a patient with ectodermal dysplasia: a case report.
The prosthodontic management of the child with ectodermal dysplasia is made difficult because of the under-development of the alveolar ridges. This paper describes a case where tricalcium phosphate was placed in sockets immediately following the extraction of the primary incisor teeth to help maintain alveolar bone width, offering a valuable alternative treatment option in the prosthodontic management of the child patient with ectodermal dysplasia.
Shankly
P E
PE
Unit of Paediatric Dentistry, University Dental Hospital of Manchester, England.
Mackie
I C
IC
McCord
F J
FJ
D016301:Alveolar Bone Loss / Q000517:prevention & control*; D000848:Anodontia / Q000209:etiology* / Q000534:rehabilitation; D018786:Bone Substitutes / Q000008:administration & dosage*; D002130:Calcium Phosphates / Q000008:administration & dosage*; D002648:Child; D017742:Dental Care for Chronically Ill; D003828:Denture, Overlay; D003832:Denture, Partial, Removable; D004476:Ectodermal Dysplasia / Q000150:complications*; D006801:Humans; D008297:Male; D010347:Patient Care Planning; D020390:Tooth Socket
D018786:Bone Substitutes; D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous